Presentation and Q&A session scheduled for
post-market on Tuesday, November 12,
2024
BOSTON, Nov. 5, 2024
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA,
"Ginkgo"), which is building the leading platform for cell
programming and biosecurity, today announced that it plans to host
a presentation and Q&A session reviewing business performance
for the third quarter ended September 30,
2024, on Tuesday, November 12,
2024, beginning at 5:30 p.m.
ET.
The presentation details and webcast link will be available on
Ginkgo's investor relations website at
https://investors.ginkgobioworks.com, and a replay will be made
available.
To ask a question ahead of the presentation, please submit them
to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to
investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell
programming, providing flexible, end-to-end services that solve
challenges for organizations across diverse markets, from food and
agriculture to pharmaceuticals to industrial and specialty
chemicals. Ginkgo Biosecurity is building and deploying the
next-generation infrastructure and technologies that global leaders
need to predict, detect, and respond to a wide variety of
biological threats. For more information, visit
ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or
follow us on social media channels such as X (@Ginkgo and
@Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads
(@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2024-results-presentation-302295611.html
SOURCE Ginkgo Bioworks
